[1]
A. A. Mohamed Yasir Arafath and B. Jaykar, “Determining the Enhancement of Oral Bioavailability VIA Solid Lipid Nanoparticles of Anticancer Drug Dasatinib - An In-vitro Cytotoxicity and Pharmacokinetic Study”, CAPRD-V2, pp. 161–168, Sep. 2021.